Jump to content

Human betaretrovirus

Add links
From Wikipedia, the free encyclopedia
(Redirected from Human mammary tumor virus)
Human betaretrovirus
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Pararnavirae
Phylum: Artverviricota
Class: Revtraviricetes
Order: Ortervirales
Family: Retroviridae
Genus: Betaretrovirus
Species:
Human betaretrovirus

Human betaretrovirus (HBRV), also known as Human mammary tumor virus, or Mouse mammary tumor-like virus is the human homologue of the Mouse mammary tumor virus (MMTV). The nomenclature for Human betaretrovirus was introduced following characterization of infection in patient with autoimmune liver disease suggesting the virus is not solely found in mice nor exclusively implicated in the development of neoplastic disease.[1][2][3] Evidence of HBRV has been documented in humans dating back at least 4500 years ago,[4][5] and it stands as the only identified exogenous betaretrovirus affecting humans to date.[6]

The existence of this virus was suspected for decades.[7] Nucleotide sequences identifying a whole proviral betarerovirus were first reported in human breast cancer in 2001[8] and lymphoid tissues of patients with autoimmune liver disease in 2003. Viral particles were isolated several years later.[9]

Virology

[edit]
Human betaretretrovirus particle isolated in co-culture with Hs578T cells from a lymph node derived from a patient with primary biliary cholangitis. The negative stained transmission electron microscopy shows a betaretrovirus-like morphology with an eccentric core and membrane spikes (Hitachi H-7650 Transmission Electron Microscope).

The HBRV encodes an approximately 9 kilobase single-stranded RNA genome, and shares significant virological similarities with MMTV.[1][6] The human and mouse betaretrovirus are difficult to distinguish genetically, and structural proteins share 93% to 99% amino acid sequence similarity with each other and less than 35% with other betaretroviruses and the human endogenous betaretroviruses (HERV-K).[1][6] By electron microscopy, both human betaretrovirus and MMTV have comparable morphological features and form 80-100 nm spherical and pleomorphic structures with eccentric nucleocapsid cores.[10][2][6]

Previously, these betaretroviruses were considered simple retroviruses encoding gag, pol and env genes but are now considered complex with the characterization of the regulator of MMTV expression (Rem) protein that acts as a nuclear export of the unspliced RNA.[11][12] The HBRV genome encodes five possible open reading frames (ORFs) that correspond with the Gag, protease (Pro), polymerase (Pol), envelope (Env), regulator of MMTV expression (Rem) and superantigen (Sag) proteins found in MMTV.[1][6][11][12] The viral superantigen is the most variable region within the betaretrovirus genome.[1] The viral superantigen mechanism is required to stimulate lymphocyte proliferation and enable viral replication within dividing cells; demonstration of superantigen activity is used to demonstrate MMTV infection in mice.[13]

Transmission

[edit]

Cross-species transmission

[edit]

The similarity of MMTV with HBRV suggests a zoonosis from mice to humans. The discovery of HBRV in humans, dating back thousands of years,[5] indicates an interspecies transmission of the virus between mice and humans coinciding with the development of agriculture. This transmission process may have resulted in the adaptation of MMTV to humans, ultimately evolving into HBRV.[4] MMTV can infect human cells, as demonstrated in co-cultivation studies using 293 human kidney, and HeLa human cervical adenocarcinoma, and Hs578T breast epithelial cells.[14][15]

HBRV transmission in humans

[edit]

The route of HBRV transmission in humans remains unknown. However, some evidence suggests the possibility of microdroplet transmission, as viral sequences have been found in human saliva.[4][16] It has been suggested that HBRV may be transmitted through saliva, as the virus can potentially reach the Waldeyer's ring structures in the throat.[4] Similar to observations in mice, both betaretrovirus particles and nucleic acid have been documented in human breast milk.[17][10] However, human milk has been shown to have a destructive effect on MMTV particles, and this route of transmission is not consistent with the epidemiological data concerning breast feeding.[18][19][20]

Tropism

[edit]

While contemporary understanding of tropism remains limited, recent studies have provided insights into HBRV's ability to infect biliary epithelial cells and replicate within lymphoid tissue.[6][21][10]

Human betaretrovirus and linked diseases

[edit]

Human betaretrovirus has been associated with various cancers[4] and autoimmune conditions, such as primary biliary cholangitis.[22] While HBRV may be a contributing factor, it is not the accepted cause at present, or the sole agent triggering these diseases. Other factors, such as genetic predisposition and other environmental exposures, are thought to play a contributary role in disease development. Nevertheless, several criteria used for linking environmental agents with disease have been firmly established for HBRV.[3][23] The over-expression in human MCF7 cells of both WNT1 and FGF3 genes, main integration sites (INT) of MMTV in mouse, induces the synthesis of epithelial mesenchymal transition markers, mitochondrial proteins, glycolytic enzymes, and protein machinery synthesis. Many of these proteins are found transcriptionally overexpressed in human breast cancer cells in vivo.[24]

Human betaretrovirus and cancer

[edit]

The potential association between human mammary tumor virus (HBRV) and breast cancer has been a subject of interest for approximately 50 years since betaretrovirus particles resembling MMTV were observed in breast milk derived from close relatives of patients with breast cancer.[10] Over the past three decades, numerous studies have provided substantial support to link a human mammary tumor virus with sporadic breast cancer and more recent research has identified viral sequences of HBRV in breast cancer samples from different regions, indicating the presence of the virus in breast cancer tissues.[25][26][27][28]

Invasive sporadic carcinoma

[edit]

More than 40 studies worldwide report evidence of HBRV infection in human sporadic breast cancer tissue ranging from ~30% to 40% of patients as compared to ~2% frequency in control samples.[4][23]

Ductal carcinoma in situ

[edit]

The rate of HBRV infection in DCIS has been found double than in invasive forms (80%). This finding indicates that HBRV plays a role in cancer initiation rather than in cancer progression, in line with what is known in the murine model.[29][30]

Hereditary carcinoma

[edit]

In contrast, hereditary breast carcinoma occurs as a result of etiopathogenetic factors unassociated with HBRV and this form of cancer has a very low frequency of HBRV ranging from 2-4%.[31] The mounting evidence regarding the potential similarity in pathogenic mechanisms between HBRV and MMTV has further strengthened the hypothesis that the virus could be relevant in understanding sporadic breast cancer development and progression.[4][32][23]

Human betaretrovirus and autoimmune diseases

[edit]

Human betaretrovirus (HBRV) has been extensively studied in its connection to the autoimmune liver disease, primary biliary cholangitis (PBC).[3] Various research approaches have been employed, including in vitro HBRV co-cultivation studies using biliary epithelium, the use of autoimmune biliary disease mouse models with MMTV infection and the study of patient samples.[3] These studies have provided valuable insights into the link between HBRV and PBC. For example, HBRV infection leads to the expression of autoantigens linked with the development of the anti-mitochondrial antibodies used to diagnose PBC,[10][33] and MMTV infection in mice is also linked with mitochondrial antigen expression and antimitochondrial antibody production.[34][35]

Using PBC patient samples, researchers have isolated HBRV and identified up to 3000 viral integration sites within the human genome, providing strong evidence of a transmissible betaretrovirus infection in patients diagnosed with PBC.[6][21] Furthermore, HBRV insertions and betaretrovirus RNA were commonly observed at the site of disease in the biliary epithelia of patients with PBC, and also in patients with autoimmune hepatitis.

Diagnosis of human betaretrovirus infection

[edit]

The diagnosis of human betaretrovirus virus infection remains a challenging task due to the lack of widely available, sensitive, and reproducible diagnostic tests. One serological ELISA assay using the HBRV Env protein was positive in 10% of breast cancer and PBC patients as compared to ~2% of healthy subjects.[36] Accordingly, this serological assay was less sensitive than the gold standard for demonstrating retroviral infection with proviral integrations. However, demonstration of genomic insertions is a research tool that is not readily adaptable for clinical use. HBRV is not readily detectable in blood by the polymerase chain reaction methodology and therefore a tissue diagnosis is required. However, this assay may be compromised by contamination. Further development of cellular immune assays using characterized HBRV Gag and Env peptides can be employed for diagnostic purposes by quantifying interferon-gamma production following stimulation of lymphocytes, providing a more sensitive assay than the ELISA.[37]

Treatment of human betaretrovirus infection

[edit]

Although there is currently no approved treatment specifically targeted for human betaretrovirus infection, some studies have demonstrated efficacy of repurposed HIV antiretroviral therapy.[38] A randomized controlled trial using combination reverse transcriptase inhibitors, lamivudine and zidovudine, did not meet the study endpoints but showed a significant improvement in alkaline phosphatase, a biliary enzyme used to gauge disease activity in PBC patients.[39] Another randomized controlled trial using the combination of tenofovir, emtricitabine, and lopinavir, was stopped early due to gastrointestinal side effects.[40] However, patients able to tolerate long-term treatment demonstrated both biochemical and histological improvement.[41][38]

The potential for immunotherapy of cancers exhibiting immunodominant betaretrovirus antigens has been studied in animal models. Using either a combination of monoclonal anti-MMTV p14 antibodies or adoptive T-cell transfer treatments, tumour growth was reduced in vivo.[42] This may have translational relevance, as related p14 antigens can be detected in benign hyperplasia patient samples predating the development of breast cancer, and in a proportion of human breast cancer samples.[43] Accordingly, the animal studies may provide a pathway for the future development of passive or active vaccination strategies to treat and possibly prevent human betaretrovirus-associated cancers.

References

[edit]
  1. ^ a b c d e Xu, Lizhe; Sakalian, Michael; Shen, Zhiwei; Loss, George; Neuberger, James; Mason, Andrew (January 11, 2004). "Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis". Hepatology. 39 (1): 151–156. doi:10.1002/hep.20024. PMID 14752833 – via CrossRef.
  2. ^ a b Xu, Lizhe; Shen, Zhiwei; Guo, Linsheng; Fodera, Brent; Keogh, Adrian; Joplin, Ruth; O'Donnell, Barbara; Aitken, James; Carman, William; Neuberger, James; Mason, Andrew (July 8, 2003). "Does a betaretrovirus infection trigger primary biliary cirrhosis?". Proceedings of the National Academy of Sciences of the United States of America. 100 (14): 8454–8459. Bibcode:2003PNAS..100.8454X. doi:10.1073/pnas.1433063100. PMC 166250. PMID 12832623.
  3. ^ a b c d Syed, Hussain; Penner, Tara; Mason, Andrew L. (September 11, 2022). "Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis". Viruses. 14 (9): 1941. doi:10.3390/v14091941. PMC 9502388. PMID 36146750.
  4. ^ a b c d e f g Bevilacqua, Generoso (August 11, 2022). "The Viral Origin of Human Breast Cancer: From the Mouse Mammary Tumor Virus (MMTV) to the Human Betaretrovirus (HBRV)". Viruses. 14 (8): 1704. doi:10.3390/v14081704. PMC 9412291. PMID 36016325.
  5. ^ a b Lessi, Francesca; Grandi, Nicole; Mazzanti, Chiara Maria; Civita, Prospero; Scatena, Cristian; Aretini, Paolo; Bandiera, Pasquale; Fornaciari, Antonio; Giuffra, Valentina; Fornaciari, Gino; Naccarato, Antonio Giuseppe; Tramontano, Enzo; Bevilacqua, Generoso (July 31, 2020). "A human MMTV-like betaretrovirus linked to breast cancer has been present in humans at least since the copper age". Aging (Albany NY). 12 (16): 15978–15994. doi:10.18632/aging.103780. PMC 7485742. PMID 32735554.
  6. ^ a b c d e f g Goubran, Mariam; Wang, Weiwei; Indik, Stanislav; Faschinger, Alexander; Wasilenko, Shawn T.; Bintner, Jasper; Carpenter, Eric J.; Zhang, Guangzhi; Nuin, Paulo; Macintyre, Georgina; Wong, Gane K.-S.; Mason, Andrew L. (April 24, 2022). "Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis". Viruses. 14 (5): 886. doi:10.3390/v14050886. PMC 9146342. PMID 35632628.
  7. ^ Moore, Dan H.; Sarkar, Nurul H.; Kramarsky, Bernhard; Lasfargues, E. Y.; Charney, Jesse (December 1971). "Some aspects of the search for a human mammary tumor virus". Cancer. 28 (6): 1415–1424. doi:10.1002/1097-0142(197112)28:6<1415::AID-CNCR2820280614>3.0.CO;2-Z. PMID 4333302.
  8. ^ Liu, B; Wang, Y; Melana, SM; Pelisson, I; Najfeld, V; Holland, JF; Pogo, BG (15 February 2001). "Identification of a proviral structure in human breast cancer". Cancer Research. 61 (4): 1754–9. PMID 11245493.
  9. ^ Melana, SM; Nepomnaschy, I; Sakalian, M; Abbott, A; Hasa, J; Holland, JF; Pogo, BG (15 September 2007). "Characterization of viral particles isolated from primary cultures of human breast cancer cells". Cancer Research. 67 (18): 8960–5. doi:10.1158/0008-5472.CAN-06-3892. hdl:11336/55456. PMID 17875739.
  10. ^ a b c d e Moore, Dan H.; Charney, Jesse; Kramarsky, Bernhard; Lasfargues, Etienne Y.; Sarkar, Nurul H.; Brennan, Michael J.; Burrows, John H.; Sirsat, Satyavati M.; Paymaster, J. C.; Vaidya, A. B. (February 11, 1971). "Search for a Human Breast Cancer Virus". Nature. 229 (5287): 611–615. Bibcode:1971Natur.229..611M. doi:10.1038/229611a0. PMID 4925461. S2CID 4175435 – via www.nature.com.
  11. ^ a b Petropoulos, C. (March 11, 1997). "Retroviral Taxonomy, Protein Structures, Sequences, and Genetic Maps". Retroviruses. Cold Spring Harbor Laboratory Press – via www.ncbi.nlm.nih.gov.
  12. ^ a b Mertz, Jennifer A.; Simper, Melissa S.; Lozano, Mary M.; Payne, Shelley M.; Dudley, Jaquelin P. (December 11, 2005). "Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus". Journal of Virology. 79 (23): 14737–14747. doi:10.1128/JVI.79.23.14737-14747.2005. PMC 1287593. PMID 16282474.
  13. ^ Held, W.; Waanders, G. A.; Shakhov, A. N.; Scarpellino, L.; Acha-Orbea, H.; MacDonald, H. R. (August 13, 1993). "Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission". Cell. 74 (3): 529–540. doi:10.1016/0092-8674(93)80054-i. PMID 8394220. S2CID 9589740 – via PubMed.
  14. ^ Indik, Stanislav; Günzburg, Walter H.; Kulich, Pavel; Salmons, Brian; Rouault, Francoise (October 11, 2007). "Rapid spread of mouse mammary tumor virus in cultured human breast cells". Retrovirology. 4 (1): 73. doi:10.1186/1742-4690-4-73. PMC 2169256. PMID 17931409.
  15. ^ Indik, Stanislav; Günzburg, Walter H.; Salmons, Brian; Rouault, Francoise (August 1, 2005). "Mouse mammary tumor virus infects human cells". Cancer Research. 65 (15): 6651–6659. doi:10.1158/0008-5472.CAN-04-2609. PMID 16061645 – via PubMed.
  16. ^ Mazzanti, Chiara Maria; Lessi, Francesca; Armogida, Ivana; Zavaglia, Katia; Franceschi, Sara; Al Hamad, Mohammad; Roncella, Manuela; Ghilli, Matteo; Boldrini, Antonio; Aretini, Paolo; Fanelli, Giovanni; Marchetti, Ivo; Scatena, Cristian; Hochman, Jacob; Naccarato, Antonio Giuseppe; Bevilacqua, Generoso (July 30, 2015). "Human saliva as route of inter-human infection for mouse mammary tumor virus". Oncotarget. 6 (21): 18355–18363. doi:10.18632/oncotarget.4567. PMC 4621895. PMID 26214095.
  17. ^ "Viruses". www.mdpi.com.
  18. ^ Henderson, Brian E. (1974). "Type B virus and human breast cancer". Cancer. 34 (S8): suppl:1386–9. doi:10.1002/1097-0142(197410)34:8+<1386::AID-CNCR2820340808>3.0.CO;2-5. PMID 4138926.
  19. ^ Sarkar, N. H.; Charney, J.; Dion, A. S.; Moore, D. H. (March 11, 1973). "Effect of human milk on the mouse mammary tumor virus". Cancer Research. 33 (3): 626–629. PMID 4120354 – via PubMed.
  20. ^ Moore, D. H. (September 11, 1974). "Evidence in favor of the existence of human breast cancer virus". Cancer Research. 34 (9): 2322–2329. PMID 4135684 – via PubMed.
  21. ^ a b Wang, W.; Indik, S.; Wasilenko, S. T.; Faschinger, A.; Carpenter, E. J.; Tian, Z.; Zhang, Y.; Wong, G. K.-S.; Mason, A. L. (February 11, 2015). "Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease". Alimentary Pharmacology & Therapeutics. 41 (4): 393–405. doi:10.1111/apt.13054. PMC 4312917. PMID 25521721.
  22. ^ Mason, Andrew; Xu, Lizhe; Neuberger, James (December 11, 2004). "Proof of principal studies to assess the role of the human betaretrovirus in patients with primary biliary cirrhosis". The American Journal of Gastroenterology. 99 (12): 2499–2500. doi:10.1111/j.1572-0241.2004.41389_1.x. PMID 15571601. S2CID 52851561 – via PubMed.
  23. ^ a b c Lawson, James S.; Glenn, Wendy K. (April 11, 2022). "Mouse Mammary Tumour Virus (MMTV) in Human Breast Cancer—The Value of Bradford Hill Criteria". Viruses. 14 (4): 721. doi:10.3390/v14040721. PMC 9028876. PMID 35458452.
  24. ^ Lamb, Rebecca; Bonuccelli, Gloria; Ozsvári, Béla; Peiris-Pagès, Maria; Fiorillo, Marco; Smith, Duncan L.; Bevilacqua, Generoso; Mazzanti, Chiara Maria; McDonnell, Liam A.; Naccarato, Antonio Giuseppe; Chiu, Maybo; Wynne, Luke; Martinez-Outschoorn, Ubaldo E.; Sotgia, Federica; Lisanti, Michael P. (October 10, 2015). "Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling". Oncotarget. 6 (31): 30453–30471. doi:10.18632/oncotarget.5852. PMC 4741544. PMID 26421711.
  25. ^ Levine, Paul H.; Pogo, Beatriz G.-T.; Klouj, Afifa; Coronel, Stephanie; Woodson, Karen; Melana, Stella M.; Mourali, Nejib; Holland, James F. (August 15, 2004). "Increasing evidence for a human breast carcinoma virus with geographic differences". Cancer. 101 (4): 721–726. doi:10.1002/cncr.20436. PMID 15305401. S2CID 42247400 – via PubMed.
  26. ^ Sm, Melana; I, Nepomnaschy; M, Sakalian; A, Abbott; J, Hasa; Jf, Holland; Bg, Pogo (September 15, 2007). "Characterization of viral particles isolated from primary cultures of human breast cancer cells". Cancer Research. 67 (18): 8960–8965. doi:10.1158/0008-5472.CAN-06-3892. hdl:11336/55456. PMID 17875739 – via pubmed.ncbi.nlm.nih.gov.
  27. ^ Nartey, Teiko; Mazzanti, Chiara M.; Melana, Stella; Glenn, Wendy K.; Bevilacqua, Generoso; Holland, James F.; Whitaker, Noel J.; Lawson, James S.; Pogo, Beatriz G. T. (March 11, 2017). "Mouse mammary tumor-like virus (MMTV) is present in human breast tissue before development of virally associated breast cancer". Infectious Agents and Cancer. 12: 1. doi:10.1186/s13027-016-0113-6. PMC 5209856. PMID 28053656.
  28. ^ Wang, Y.; Holland, J. F.; Bleiweiss, I. J.; Melana, S.; Liu, X.; Pelisson, I.; Cantarella, A.; Stellrecht, K.; Mani, S.; Pogo, B. G. (November 15, 1995). "Detection of mammary tumor virus env gene-like sequences in human breast cancer". Cancer Research. 55 (22): 5173–5179. PMID 7585568 – via PubMed.
  29. ^ Mazzanti, Chiara Maria; Al Hamad, Mohammad; Fanelli, Giovanni; Scatena, Cristian; Zammarchi, Francesca; Zavaglia, Katia; Lessi, Francesca; Pistello, Mauro; Naccarato, Antonio Giuseppe; Bevilacqua, Generoso (October 11, 2011). "A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma". The American Journal of Pathology. 179 (4): 2083–2090. doi:10.1016/j.ajpath.2011.06.046. PMC 3181336. PMID 21854742.
  30. ^ Callahan, Robert; Mudunur, Uma; Bargo, Sharon; Raafat, Ahmed; McCurdy, David; Boulanger, Corinne; Lowther, William; Stephens, Robert; Luke, Brian T.; Stewart, Claudia; Wu, Xiaolin; Munroe, David; Smith, Gilbert H. (November 11, 2012). "Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors". Oncotarget. 3 (11): 1320–1334. doi:10.18632/oncotarget.682. PMC 3717796. PMID 23131872.
  31. ^ Naccarato, Antonio Giuseppe; Lessi, Francesca; Zavaglia, Katia; Scatena, Cristian; Al Hamad, Mohammad A.; Aretini, Paolo; Menicagli, Michele; Roncella, Manuela; Ghilli, Matteo; Caligo, Maria Adelaide; Mazzanti, Chiara Maria; Bevilacqua, Generoso (September 13, 2019). "Mouse mammary tumor virus (MMTV) - like exogenous sequences are associated with sporadic but not hereditary human breast carcinoma". Aging (Albany NY). 11 (17): 7236–7241. doi:10.18632/aging.102252. PMC 6756874. PMID 31518337.
  32. ^ Parisi, Francesca; Freer, Giulia; Mazzanti, Chiara Maria; Pistello, Mauro; Poli, Alessandro (May 6, 2022). "Mouse Mammary Tumor Virus (MMTV) and MMTV-like Viruses: An In-depth Look at a Controversial Issue". Viruses. 14 (5): 977. doi:10.3390/v14050977. PMC 9147501. PMID 35632719.
  33. ^ "Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis - The Lancet".
  34. ^ Zhang, Guangzhi; Chen, Min; Graham, Don; Subsin, Benchamas; McDougall, Chelsea; Gilady, Suzanna; Kneteman, Mark; Law, Lok; Swain, Mark; Trauner, Michael; Wrzesinski, Stephen; Flavell, Richard; Wasilenko, Shawn; Mason, Andrew (October 11, 2011). "Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models". Journal of Hepatology. 55 (4): 876–884. doi:10.1016/j.jhep.2011.01.037. PMID 21334408 – via PubMed.
  35. ^ Sharon, David; Chen, Min; Zhang, Guangzhi; Girgis, Safwat; Sis, Banu; Graham, Don; McDougall, Chelsea; Wasilenko, Shawn T.; Montano-Loza, Aldo; Mason, Andrew L. (April 11, 2015). "Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease". Liver International. 35 (4): 1442–1450. doi:10.1111/liv.12699. PMC 4403978. PMID 25302564.
  36. ^ "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease - HINDAWI" (PDF).
  37. ^ "Cellular Immune responses to human betaretrovirus in patients with primary biliary cholangitis" (PDF).
  38. ^ a b Turvey, Shannon L.; Saxinger, Lynora; Mason, Andrew L. (March 3, 2022). "Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis". Viruses. 14 (3): 516. doi:10.3390/v14030516. PMC 8949089. PMID 35336923.
  39. ^ Mason, A. L.; Lindor, K. D.; Bacon, B. R.; Vincent, C.; Neuberger, J. M.; Wasilenko, S. T. (October 1, 2008). "Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol". Alimentary Pharmacology & Therapeutics. 28 (7): 886–894. doi:10.1111/j.1365-2036.2008.03799.x. PMID 18627363 – via PubMed.
  40. ^ Lytvyak, Ellina; Hosamani, Ishwar; Montano-Loza, Aldo J; Saxinger, Lynora; Mason, Andrew L (2019). "Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis". Canadian Liver Journal. 2 (1): 31–44. doi:10.3138/canlivj.2018-0020. PMC 8112609. PMID 33981960.
  41. ^ Lytvyak, E.; Niazi, M.; Pai, R.; He, D.; Zhang, G.; Hübscher, S. G.; Mason, A. L. (2021). "Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation". Liver International. 41 (8): 1879–1883. doi:10.1111/liv.14964. PMC 8362166. PMID 34008271.
  42. ^ Hochman, Jacob; Braitbard, Ori (November 2, 2022). "Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human Breast Cancer". Viruses. 14 (11): 2435. doi:10.3390/v14112435. PMC 9694287. PMID 36366533.
  43. ^ Lawson, James S.; Mazzanti, Chiara; Civita, Prospero; Menicagli, Michele; Ngan, Christopher C.; Whitaker, Noel J.; Hochman, Jacob; Braitbard, Ori; Yosufi, Benafsha; Glenn, Wendy K. (March 11, 2018). "Association of Mouse Mammary Tumor Virus With Human Breast Cancer: Histology, Immunohistochemistry and Polymerase Chain Reaction Analyses". Frontiers in Oncology. 8: 141. doi:10.3389/fonc.2018.00141. PMC 5950654. PMID 29868468.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Human_betaretrovirus&oldid=1244844881"